About Rodolfo Chaparro
Rodolfo Chaparro co-founded Crosslink Therapeutics and serves as its scientific advisor. Crosslink develops cancer medicines for people with solid tumors. He also co-invented Crosslink's technologies.
He previously co-founded Cue Biopharma and co-invented its licensed core technologies. He served as executive vice president and head of immunology. He oversaw Cue's immuno-oncology and autoimmunity research. He also led its preclinical and early clinical development. Before Cue, he was a research faculty member in biochemistry at Albert Einstein College of Medicine. He held that faculty role from 2010 to 2014 and later became head of immunology within MTDF. He began at Einstein as a postdoctoral fellow in 2004. He earned a biology degree from UC Irvine and a doctorate in immunology from Stanford.
Experience
This experience comes from official bios, from Rodolfo Chaparro's profile and from SEC filings. For roles taken from filings, the years are when the filings name Rodolfo Chaparro in the role, so the role may have started earlier or lasted longer.
Key Colleagues at Startups
The people Rodolfo Chaparro works with at each company, as listed on that company's latest Form D.
